These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 11035907)

  • 21. Recurrent fractures in an elderly patient with systemic lupus erythematosus.
    Chia FL; Thong BY; Lau TC; Feng PH
    Int J Rheum Dis; 2009 Sep; 12(3):256-63. PubMed ID: 20374356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suggested guidelines for evaluation and treatment of glucocorticoid-induced osteoporosis for the Department of Veterans Affairs.
    Adler RA; Hochberg MC
    Arch Intern Med; 2003 Nov; 163(21):2619-24. PubMed ID: 14638562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Medical prophylaxis and treatment of steroid induced osteoporosis].
    Rødevand E; Mikkelsen K; Nordvåg BY; Haga HJ; Førre Ø; Johnsen V; Kvien TK
    Tidsskr Nor Laegeforen; 2005 Jun; 125(12):1643-5. PubMed ID: 15976829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pathogenesis, epidemiology and management of glucocorticoid-induced osteoporosis.
    van Staa TP
    Calcif Tissue Int; 2006 Sep; 79(3):129-37. PubMed ID: 16969593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Vitamin K2 as a potential therapeutic agent for glucocorticoid-induced osteoporosis].
    Tanaka I; Oshima H
    Clin Calcium; 2007 Nov; 17(11):1738-44. PubMed ID: 17982195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antiepileptic drug-induced osteopathy. Subtypes, pathogenesis, prevention, early diagnosis and treatment].
    Bartl R
    Dtsch Med Wochenschr; 2007 Jul; 132(27):1475-9. PubMed ID: 17583832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review article: Osteoporosis and inflammatory bowel disease.
    Bernstein CN; Leslie WD
    Aliment Pharmacol Ther; 2004 May; 19(9):941-52. PubMed ID: 15113361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Glucocorticoid-induced osteoporosis: review and proposition for prevention and treatment guidelines].
    Grazio S; Korsić M; Anić B; Vitezić-Misjak M; Grubisić F
    Lijec Vjesn; 2005; 127(1-2):36-43. PubMed ID: 16145872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention and treatment of glucocorticoid-induced osteoporosis.
    Doga M; Mazziotti G; Bonadonna S; Patelli I; Bilezikian JP; Canalis E; Giustina A
    J Endocrinol Invest; 2008 Jul; 31(7 Suppl):53-8. PubMed ID: 18791353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis.
    van Staa TP; Leufkens HG; Cooper C
    Osteoporos Int; 2002 Oct; 13(10):777-87. PubMed ID: 12378366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corticosteroid-induced osteoporosis in patients with uveitis.
    Jones NP; Anderton LC; Cheong FM; Whallett A; Stanford MR; Murray PI; Lesnik-Oberstein S; Pavesio C
    Eye (Lond); 2002 Sep; 16(5):587-93. PubMed ID: 12194074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vertebral fracture and bone mineral density in women receiving high dose glucocorticoids for treatment of autoimmune diseases.
    Kumagai S; Kawano S; Atsumi T; Inokuma S; Okada Y; Kanai Y; Kaburaki J; Kameda H; Suwa A; Hagiyama H; Hirohata S; Makino H; Hashimoto H
    J Rheumatol; 2005 May; 32(5):863-9. PubMed ID: 15868623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Secondary osteoporosis. Glucocorticoid-induced osteoporosis: Threshold of bone mineral density for vertebral fracture].
    Soen S
    Clin Calcium; 2007 Mar; 17(3):399-402. PubMed ID: 17339745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What is new in the treatment of steroid-induced osteoporosis?
    Liu RH; Werth VP
    Semin Cutan Med Surg; 2007 Dec; 26(4):203-9. PubMed ID: 18395668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men.
    Cruse LM; Valeriano J; Vasey FB; Carter JD
    J Clin Rheumatol; 2006 Oct; 12(5):221-5. PubMed ID: 17023807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Secondary osteoporosis. Pathogenesis of glucocorticoid-induced osteoporosis].
    Takayanagi R
    Clin Calcium; 2007 Feb; 17(2):270-4. PubMed ID: 17272886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A cost effectiveness analysis of calcium and vitamin D supplementation, etidronate, and alendronate in the prevention of vertebral fractures in women treated with glucocorticoids.
    Buckley LM; Hillner BE
    J Rheumatol; 2003 Jan; 30(1):132-8. PubMed ID: 12508402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Male osteoporosis: current treatments and future options].
    Romagnoli E; Paglia F; Dionisi S; De Geronimo S; Pepe J; Di Virgilio R; Minisola S
    Clin Ter; 2003; 154(1):49-53. PubMed ID: 12854284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Biochemical markers of bone in steroid (glucocorticoid)-induced osteoporosis (GIOP)].
    Masaki H; Miki T
    Clin Calcium; 2006 Nov; 16(11):1823-32. PubMed ID: 17079849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prevention and treatment of osteoporosis: a review.
    Cosman F
    MedGenMed; 2005 May; 7(2):73. PubMed ID: 16369451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.